Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3 Read more about Treatment of Non-severe Covid-19 Outpatients With Xagrotin, Phase 3
Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON) Read more about Intersectoral Platform (SÜP) of the National Pandemic Cohort Network (NAPKON)
Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B) Read more about Clinical Validation of the LumiraDx SARS-CoV-2 & Flu A/B Test in Detecting and Differentiating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), Influenza A (Flu A), and/or Influenza B (Flu B)
Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19 Read more about Dapsone Coronavirus SARS-CoV-2 Trial (DAP-CORONA) COVID-19
Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study. Read more about Sisonke 2 - A COVID-19 Vaccine Boost Open Label Study.
Sleep Quality and Quality of Life in Coronavirus 19 Disease ( COVID 19) Patients Read more about Sleep Quality and Quality of Life in Coronavirus 19 Disease ( COVID 19) Patients
Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older Read more about Booster Superiority Study of PTX-COVID19-B Compared to Vaxzevria® in Adults Aged 18 Years and Older
Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study Read more about Identification of Novel Factors Leading to Activated Macrophage Expansion in COVID19 - INFLAME Study
COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients Read more about COVID-19 Vaccination Status and The Clinical Outcomes of Long COVID-19 Patients
Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19 Read more about Impact of Genetic Polymorphisms of Vasoactive Peptides on the Prognosis of Patients With COVID19